keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | $ 288.00 | |
5 mg | Inquiry | $ 783.00 |
Description | Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue. |
Synonyms | Ac2-26 TFA |
Molecular Weight | 3203.45 |
Formula | C143H211F3N32O46S |
CAS No. | TP1321 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ac2-26 TFA (151988-33-9 free base) TP1321 Ac2 26 TFA (151988 33 9 free base) 151988-33-9 Ac-2-26 TFA (151988-33-9 free base) Ac226 TFA (151988339 free base) Ac2-26 TFA 151988-33-9 free base inhibitor inhibit